Format

Send to

Choose Destination
Expert Opin Ther Targets. 2008 Oct;12(10):1301-12. doi: 10.1517/14728222.12.10.1301 .

Chromatin-modifying enzymes as therapeutic targets--Part 1.

Author information

1
National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina 27709, USA.

Abstract

BACKGROUND:

Disease pathogenesis may result from genetic alterations and/or a more diverse group of epigenetic changes. While events such as DNA methylation are well established, there is significant interest in nucleosome remodeling, RNA interference and histone modifications, as mechanisms that underlie epigenetic effects. While genetic mutations are permanent, epigenetic changes can be transitory. The potential to reverse epigenetic changes has led to the development of therapeutic strategies targeting chromatin-modifying enzymes.

OBJECTIVE:

To review the roles of chromatin-modifying enzymes in gene regulation and to highlight their potentials as therapeutic targets.

METHODS:

This review is based on recently published literature and online resources.

RESULTS/CONCLUSION:

This paper focuses on enzymes responsible for histone acetylation, deacetylation, methylation and demethylation, and their potential as targets for epigenetic therapies. A subsequent paper will do the same for enzymes responsible for histone phosphorylation, ubiquitylation, SUMOylation and poly-ADP-ribosylation as well as ATP-dependent nucleosome remodeling.

PMID:
18781828
PMCID:
PMC2761090
DOI:
10.1517/14728222.12.10.1301
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center